About Company
- Overview
- Information
- Review

Serenus.AI
Israel
15 Mar 2017 (8 Years)
Last online: No recent activity
No Review
Not enough to calculate score
Provided by TrustFinance
Verification on TrustFinance
0.00
Traffic & Engagement
1.67
This company no score yet, be the first to review
Provided by TrustFinance
Security Information
What are the differences in regulations for each
License
A Grade License
Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.
B Grade License
Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.
C Grade License
Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.
D Grade License
From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.
Company Information
Get to know Serenus.AI
Company Information
Get to know Serenus.AI
Serenus.AI has a strong passion to improve healthcare delivery and patients' outcome. Its unique patented technology was developed to improve medical treatment decisions, saving lives, and valuable resources. Among the Serenus.AI team are top medical experts from various medical fields and machine learning specialists. The innovative solution was already validated in practice and the company is currently active in Europe and the US with leading stakeholders in the healthcare field. The company received grants from 4 government entities in Israel who validated its innovation and technology, including the Ministry of Health, Ministry of Economics, the Innovation Authority, and the Bilateral US-Israel Bird Award. Please also see articles about our solution: https://www.extra-mag.co.il/making-an-informed-decision/ https://www.yorkshireeveningpost.co.uk/health/can-smart-robot-match-surgeons-skills-leeds-researchers-will-find-out-2005357 https://datarootlabs.com/blog/ai-in-healthcare-how-ai-startups-disrupt-the-healthcare-industry Hillary Orly Harel | CEO and Co-Founder of Serenus.AI: Winner | Winner of Department for International Trade (DIT)'s first-ever "2020 European Women in Tech" Finalist | Winner of Quesnay's Female Founders in InsurTech 2020" Named | Winner of Top AI start-up company in "Healthcare Innovation Landscape 2020" Data Roots Labs report Named | Winner of 58th Most Influential Woman in the Tech World
Industry
- Financial InsurancePRIMARY
Contact
-
-
-
-
Social
Company hasn't updated its information.
Users who look Serenus.AI also look…
Reviews
Social Scout
See what Social Scout found of Serenus.AI
Provided by TrustFinance AI Analysis
Serenus.AI Reviews
Reviews
Total 0
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis
Filter
5 Star
4 Star
3 Star
2 Star
1 Star
Sort by
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis



